Abstract
Abstract B101 Background Betulinic acid is a naturally occurring lupane-type pentacyclic triterpenoid with great activity in the treatment and prevention of cancer. As an apoptosis inducer, it inhibits cancer cell growth in human melanoma, glioblastoma, neuroblastoma, leukemia, prostate and ovarian carcinomas. Several studies have linked the anticancer property of betulinic acid to its ability to induce apoptosis in cancer cells by targeting the mitochondrial pathway of apoptosis. We have been interested in the structure -activity studies of modified lupane-type pentacyclic triterpenoids to develop new cancer preventive drugs with enhanced pro-apoptotic activities. Methods New compounds were prepared in five to seven synthetic steps. The panel of cell lines used in our investigation included SK-MEL-2 and A-375 from malignant melanoma of the skin, Daoy and LN-229 from cerebellar medulloblastoma, OVCAR-3 from ovarian, HT-29 from colorectal adenocarcinoma and MCF-7 from breast adenocarcenoma clinical samples. Cell growth inhibitory activity was measured by tetrazolium-based MTS assay and reported as IC50 values. Homogeneous caspase activation was quantified by a fluorimetric assay and apoptosis induction was characterized by an annexin-type flow cytometry assay and measured as ratio of early-mid apoptotic to necrotic cells. Results The structure -activity relationship analysis reveals that amino group incorporation has significant impact on the cytotoxicty of triterpenes. Mono-amino derivatives inhibited cancer cell growth with potency 2-6 times higher than betulinic acid, whereas bis-amino analogues exhibited inhibitory effect with IC50 values of 10-100 times lower. Further mechanism of action studies revealed that these new amino pentacyclic triterpenoids induced apoptosis and activated caspases. In SK-MEL-2 (melanoma) cells, apoptosis was induced as early as 2 h at 15 μM and a similar amount of apoptosis induction was observed at 16 h in Daoy (glioblastoma) cells. Conclusions Our results show that incorporation of amino groups into the structure of lupane-type pentacyclic triterpenoids at various positions markedly improves cytotoxicity of these molecules with unique apoptosis induction ability. Further pharmacological evaluation on this new class of modified natural products is warranted to develop promising agents for cancer treatment and prevention. Citation Information: Cancer Prev Res 2008;1(7 Suppl):B101.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
